BLB^B Advisors »

Karyopharm Therapeutics Inc note 3.000%10/1 shares owned by BLB^B Advisors

Quarter-by-quarter ownership of Karyopharm Therapeutics Inc note 3.000%10/1 shares owned by BLB^B Advisors from 13F filings

Historical chart of BLB^B Advisors investment in Karyopharm Therapeutics Inc note 3.000%10/1

Tip: Access up to 7 years of quarterly data

All positions including Karyopharm Therapeutics Inc note 3.000%10/1 held by BLB^B Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Karyopharm Therapeutics Inc note 3.000%10/1 by BLB^B Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $37k 75k 0.49
2023-09-30 $46k 75k 0.61
2023-06-30 $50k 75k 0.67
2023-03-31 $58k 75k 0.77
2022-12-31 $57k 75k 0.75
2022-09-30 $60k 75k 0.80
2022-06-30 $73k 100k 0.73
2022-03-31 $84k 100k 0.84

More positions owned by BLB^B Advisors

Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Core S&p Scp Etf (IJR)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core S&p Mcp Etf (IJH)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Microsoft Corporation (MSFT)
Apple (AAPL)
Ishares Tr Core Us Aggbd Et (AGG)
Schwab Strategic Tr Us Mid-cap Etf (SCHM)
Barclays Bank Djubs Cmdt Etn36 (DJP)
Ishares Tr Core S&p Ttl Stk (ITOT)
Ishares Core Msci Emkt (IEMG)
Vanguard Index Fds Small Cp Etf (VB)
Vanguard Index Fds Mid Cap Etf (VO)
NVIDIA Corporation (NVDA)

View all positions for BLB^B Advisors

Top funds holding Karyopharm Therapeutics Inc note 3.000%10/1

Braidwell
Highbridge Capital Management
Davidson Kempner Capital Management
Context Capital Management
Birch Grove Capital
Capstone Investment Advisors
Lazard Asset Management
DeepCurrents Investment Group
BLB^B Advisors
Jpmorgan Chase & Co

View all funds holding Karyopharm Therapeutics Inc note 3.000%10/1